Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enso is a medical technology company that developed a non-invasive, wearable device designed to provide rapid and long-term relief for chronic and musculoskeletal pain. The company's flagship product uses high-frequency electrical stimulation to calm overactive nerves, offering a drug-free alternative to traditional pain management treatments like opioids or surgery. In 2021, Enso was acquired by Hinge Health to integrate its wearable technology into a comprehensive digital musculoskeletal clinic. The device is clinically validated and has demonstrated significant reductions in pain levels and improvements in physical function for patients with back and joint pain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enso.